Clinical trial
A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In…
NCT00468975 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00468975 |
|---|---|
| Title | A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients. |
| Official title | A Phase IIA Randomised, Double-blind, Double Dummy, Placebo and Active Controlled 5-Way Cross-over Trial to Examine the Bronchodilator Effects of PF-610,355 and to Test for Superiority Versus Placebo in Reversible Asthmatic Patients |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | PF-610, 355, Salmeterol |
| Enrollment | 42 |
| Start date | May 1, 2007 |
| First posted | May 3, 2007 |
| Last update posted | Nov 1, 2010 |
| Countries | Germany, Sweden, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: